Investor · Los Angeles, CA
John S. Yu
Open John in the network graph →Filings
27
SEC Form D
Connections
37
co-filers
Capital
$3.5M
across filings
Active
Mar 2011
to Jan 2025
Most-connected co-filers (37)
Robert L. Martuza · WOODLAND HILLS, CA21 sharedStewart H. Greenfield · Southport, CT21 sharedAlexandre P. Antebi · Palo Alto, CA21 sharedMadelyn B. Smith · Wilmington, DE21 sharedLord John Michael Edward L. Moore · Wilmington, DE21 sharedJames M. Keyes · Hamilton, Bermuda21 sharedMarvin & Palmer Associates, Inc · Wilmington, DE18 sharedMarvin & Palmer Associates, Inc · Wilmington, DE18 sharedDavid K. Storrs · Southport, CT14 sharedTodd D. Marvin · Wilmington, DE14 sharedScott Friend · New York, NY10 sharedN. Marvin & Palmer Associates, Inc · Wilmington, DE3 sharedJacqueline Brandwynne · Seattle, WA3 sharedC. K. Peacock · Seattle, WA3 sharedManish Singh · WOODLAND HILLS, CA3 sharedJames Bender · WOODLAND HILLS, CA3 sharedRichard A. Cowell · WOODLAND HILLS, CA3 sharedNavdeep Jaikaria · WOODLAND HILLS, CA3 sharedN. Marvin & Palmer Associates, Inc · Wilmington, DE3 sharedMichael S. Burke · Vancouver, British Columbia, Canada2 sharedFrancis S. Bong · Los Angeles, CA2 sharedDoug S. Samuelson · Los Angeles, CA2 sharedRamachandran S. Murali · Los Angeles, CA2 sharedNeil S. Bhowmick · Los Angeles, CA2 shared
Recent filings (27)
Kairos Pharma, LTD.Jan 2025 · 13 co-filers$8.8MKairos Pharma, LTD.Jan 2025 · 13 co-filers$8.8MKairos Pharma, LTD.Apr 2023 · 9 co-filers$3.0MKairos Pharma, LTD.Apr 2023 · 9 co-filers$3.0MH3D, Inc.Sep 2017 · 4 co-filers$2.8MMARVIN & PALMER NON US EQUITY L PFeb 2012 · 11 co-filersMARVIN & PALMER NON US EQUITY INSTITUTIONAL FUND LPFeb 2012 · 11 co-filersMARVIN & PALMER US EQUITY LPFeb 2012 · 11 co-filersMARVIN & PALMER EMERGING MARKETS EQUITY L PFeb 2012 · 12 co-filersMARVIN & PALMER GLOBAL PARTNERS FUND LPFeb 2012 · 11 co-filersMARVIN & PALMER EMERGING MARKETS PARTNERS FUND L PFeb 2012 · 10 co-filersMARVIN & PALMER GLOBAL EQUITY LPFeb 2012 · 10 co-filersImmunoCellular Therapeutics, Ltd.Mar 2011 · 9 co-filers$8.1MImmunoCellular Therapeutics, Ltd.Mar 2011 · 9 co-filers$8.1MMARVIN & PALMER GLOBAL PARTNERS FUND LPFeb 2011 · 10 co-filersMARVIN & PALMER US EQUITY LPFeb 2011 · 11 co-filersMARVIN & PALMER NON US EQUITY INSTITUTIONAL FUND LPFeb 2011 · 10 co-filersMARVIN & PALMER EMERGING MARKETS PARTNERS FUND L PFeb 2011 · 11 co-filersMARVIN & PALMER NON US EQUITY L PFeb 2011 · 11 co-filersMARVIN & PALMER EMERGING MARKETS EQUITY L PFeb 2011 · 11 co-filersMARVIN & PALMER GLOBAL EQUITY LPFeb 2011 · 11 co-filersImmunoCellular Therapeutics, Ltd.Jun 2010 · 15 co-filers$2.7MImmunoCellular Therapeutics, Ltd.Apr 2010 · 15 co-filers$1.7MMARVIN & PALMER GLOBAL EQUITY LPMar 2010 · 8 co-filersMARVIN & PALMER GLOBAL PARTNERS FUND LPMar 2010 · 8 co-filers
Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See John in the interactive graph →